SEC Form 4 · accession 0001209191-15-043016
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carmen R Rodriguez
Officer — Snr VP Reg Afrs & Qual. Assur.
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 9:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2015 | M | 13,895 | $6.96 | A | 26,915 | D | |
| Common StockF1 | May 12, 2015 | S | 13,895 | $62.0538 | D | 13,020 | D | |
| Common Stock | May 12, 2015 | M | 279 | $6.92 | A | 13,299 | D | |
| Common StockF1 | May 12, 2015 | S | 279 | $62.0538 | D | 13,020 | D | |
| Common Stock | May 13, 2015 | M | 14,715 | $5.59 | A | 27,735 | D | |
| Common StockF2 | May 13, 2015 | S | 14,715 | $62.0925 | D | 13,020 | D | |
| Common Stock | May 13, 2015 | M | 15,666 | $17.14 | A | 28,686 | D | |
| Common StockF3 | May 13, 2015 | S | 15,666 | $63.1891 | D | 13,020 | D | |
| Common Stock | May 13, 2015 | M | 11,387 | $12.49 | A | 24,407 | D | |
| Common StockF4 | May 13, 2015 | S | 11,387 | $63.1957 | D | 13,020 | D | |
| Common StockF5 | May 14, 2015 | S | 6,000 | $63.7585 | D | 7,020 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $6.96 | May 12, 2015 | M | 13,895 | D | — | Apr 12, 2023 | Common Stock | 13,895 | 15,105 | D |
| Stock Option (right to buy)F7 | $6.92 | May 12, 2015 | M | 279 | D | — | Mar 31, 2021 | Common Stock | 279 | 5,721 | D |
| Stock Option (right to buy)F8 | $5.59 | May 13, 2015 | M | 14,715 | D | — | Mar 13, 2022 | Common Stock | 14,715 | 10,285 | D |
| Stock Option (right to buy)F9 | $17.14 | May 13, 2015 | M | 15,666 | D | — | Feb 7, 2024 | Common Stock | 15,666 | 31,334 | D |
| Stock Option (right to buy)F10 | $12.49 | May 13, 2015 | M | 11,387 | D | — | Nov 7, 2023 | Common Stock | 11,387 | 18,613 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.35, inclusive.
- F101/4th of the shares subject to such option shall vest and become exercisable on October 1, 2014 and 1/48th of the shares subject to such option shall vest and become exercisable each month thereafter, until all are vested.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.23, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.015 to $63.44, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.10 to $63.285, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.50 to $64.18, inclusive.
- F61/4th of the shares subject to such option shall vest and become exercisable on April 1, 2014 and 1/48th of the shares subject to such option shall vest and become exercisable each month thereafter, until all are vested.
- F7This option is fully vested and exercisable.
- F81/4th of the shares subject to such option shall vest and become exercisable on January 1, 2013 and 1/48th of the shares subject to such option shall vest and become exercisable each month thereafter, until all are vested
- F91/4th of the shares subject to such option shall vest and become exercisable on January 1, 2015 and 1/48th of the shares subject to such option shall vest and become exercisable each month thereafter, until all are vested.